These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24576279)

  • 41. [Infiltrative cardiomyopathy and beta fibrillosis caused by kappa light chains (primary amyloidosis) without myeloma].
    Reyes PA; Hidalgo MA; Huerta D; Bialostozky D
    Arch Inst Cardiol Mex; 1983; 53(1):17-22. PubMed ID: 6409015
    [No Abstract]   [Full Text] [Related]  

  • 42. [Amyloid cardiomyopathy: a link between cardiology and hematology. A case report of positive response to standard therapy].
    Petrillo G; Catalano L; Petruzziello F; Padula S; Petrillo C; Caso P
    G Ital Cardiol (Rome); 2007 Jun; 8(6):371-6. PubMed ID: 17633911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amyloidosis: clinical pentad.
    Mookadam F; Mookadam M; Jiamsripong P
    Intern Med J; 2011 Jan; 41(1a):66-7. PubMed ID: 21265964
    [No Abstract]   [Full Text] [Related]  

  • 44. Amyloidosis of the heart. Possible pitfall in the diagnosis of pericardial effusion by scintillation scanning.
    Hauser W; Atkins HL; Richards P
    JAMA; 1968 May; 204(7):628-30. PubMed ID: 5694496
    [No Abstract]   [Full Text] [Related]  

  • 45. Cardiac amyloidosis.
    Kingman A; Pereira NL
    J S C Med Assoc; 2001 May; 97(5):201-6. PubMed ID: 11381776
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis.
    Ng B; Connors LH; Davidoff R; Skinner M; Falk RH
    Arch Intern Med; 2005 Jun; 165(12):1425-9. PubMed ID: 15983293
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis.
    Palladini G; Campana C; Klersy C; Balduini A; Vadacca G; Perfetti V; Perlini S; Obici L; Ascari E; d'Eril GM; Moratti R; Merlini G
    Circulation; 2003 May; 107(19):2440-5. PubMed ID: 12719281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Harnessing Cardiac Regeneration as a Potential Therapeutic Strategy for AL Cardiac Amyloidosis.
    Joshi S; Evangelisti A; Liao R; Alexander KM
    Curr Cardiol Rep; 2020 Jan; 22(1):1. PubMed ID: 31932992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Infiltrative cardiomyopathy due to AL amyloidosis.
    Batrani M; Marwah S; Buxi G; Sharma SC
    Indian J Pathol Microbiol; 2008; 51(4):566-8. PubMed ID: 19008602
    [No Abstract]   [Full Text] [Related]  

  • 50. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 40-1988. A 62-year-old woman with right-sided congestive heart failure.
    N Engl J Med; 1988 Oct; 319(14):932-43. PubMed ID: 3138538
    [No Abstract]   [Full Text] [Related]  

  • 51. Immunoglobulin D and cardiac amyloidosis: development and a case illustration.
    Servonnet A; Bouvier F; Garcia Hejl C; Sanmartin N; Renard C
    Ann Biol Clin (Paris); 2016 Jun; 74(3):329-32. PubMed ID: 27237804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Congestive heart failure in a 70-year-old man.
    Willerson JT; Chen PC; Hartwell EA; Buja LM
    Circulation; 1993 Sep; 88(3):1336-47. PubMed ID: 8353894
    [No Abstract]   [Full Text] [Related]  

  • 53. [The femoropatellar joint].
    Wybier M
    Ann Radiol (Paris); 1993; 36(3):195-9. PubMed ID: 8239452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Imaging of amyloid arthropathy.
    Sheldon PJ; Forrester DM
    Semin Musculoskelet Radiol; 2003 Sep; 7(3):195-203. PubMed ID: 14593561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A first step beyond traditional boundaries: destination therapy with the SynCardia total artificial heart.
    Spiliopoulos S; Koerfer R; Tenderich G
    Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):855-6. PubMed ID: 24632422
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent advances in the diagnosis and management of cardiac amyloidosis.
    Sher T; Gertz MA
    Future Cardiol; 2014 Jan; 10(1):131-46. PubMed ID: 24344669
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [CARDIAC AMYLOIDOSIS. DIAGNOSTICS AND TREATMENT OF AMYLOID CARDIOMYOPATHY. CASE REPORT].
    Nonka TG; Repin AN
    Klin Med (Mosk); 2015; 93(4):66-73. PubMed ID: 26155713
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Functional methods of amyloid cardiomyopathy diagnostic in practice and in expert centers: A review].
    Dzhioeva ON
    Ter Arkh; 2023 Feb; 95(1):96-102. PubMed ID: 37167121
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nondilated cardiomyopathies.
    Johnson RA; Palacios I
    Adv Intern Med; 1984; 30():243-74. PubMed ID: 6397036
    [No Abstract]   [Full Text] [Related]  

  • 60. Radionuclide Imaging in Congestive Heart Failure: Assessment of Viability, Sarcoidosis, and Amyloidosis.
    Bois JP; Chareonthaitawee P
    Cardiol Clin; 2016 Feb; 34(1):119-32. PubMed ID: 26590784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.